Established Safety Profile# Recommendation : CagriSema Reason : Builds on semaglutide's 7+ year post-marketing safety record and over 25,000 clinical trial participants
\n\n\n\n From a sports and athletics perspective, BPC-157 is monitored by WADA (the World Anti-Doping Agency) under its category of peptide hormones, growth factors, and related substances
Research labs need this level of purity to minimize variables that can affect the results
NNMT expression is elevated in adipose tissue in obesity, and NNMT activity is associated with lower adipocyte energy expenditure
Knezevic et al., 2021b) or more (high intra-abdominal hypertension compressing all blood vessels), with either specific injury (vessel ligation) (Vukojevic et al., 2018
Short-term studies in animal models suggest BPC-157 is well tolerated and associated with mild adverse events when they do occur